novel agents has recently been investigated in both transplant-eligible and -ineligible myeloma patients. In Phase III trials, thalidomide, lenalidomide and bortezomib have consistently improved progression-free…
cause of end-stage kidney disease worldwide. One strategy to prevent the development and progression of diabetic kidney disease is intensive blood glucose control. Randomized controlled trials such ... DCCT have…
limbs. Over the last five decades there has been little progress in the development of oral anticoagulant therapies. However, recently this area has been experiencing a rapidly changing situation thanks
autosomal recessive, neurodegenerative disease. It affects primarily the nervous system and the heart. Progressive gait and limb ataxia, dysarthria, loss of vibration and proprioceptive sense are characteristic…
against an antigen/microbe may well be relevant for Type 1 diabetes (T1D) but progress takes time. Use of probiotics is another way of influencing the immune system ... subcutaneous ‘vaccination’ with GAD-alum has shown…
either glucose-defined diabetes or IGR. The aim of this article is to review recent studies from countries around the globe to assess these issues. Using HbA1c, greater than ... people without diabetes, HbA1c begins to…
nilotinib showed high activity in imatinib-resistant or -intolerant chronic myeloid leukemia patients. Recently, the results of nilotinib as frontline treatment showed high efficacy and superiority as compared with…
Impaired b‑cell function in Type 2 diabetes mellitus (T2DM) is generally progressive. The commonly used sulfonylureas (SU) lose efficacy over time and are associated with impaired b‑cell function ... function, and…
children and it is responsible for short and long-term disability. In the recent years an increased number of disease-modifying anti-rheumatic drugs (DMARDs) have been developed for treatment ... exposing of patients to…
rapid progression of the disease may lead to orbital and brain involvement. In the past, the mortality rate of the rhino-cerebral type was 88%, but recently the survival rate
crucial for the establishment of the chronic phase of the infection and the disease progression. Indeed, the early infection is crucial for establishing the reservoirs and, thus, the chronic phase ... from PHI by…
smoking cessation, the consumption of a healthy diet, regular foot care and glycemic checks. Recent meta-analyses have clearly demonstrated the value of self-management yet no consistent pattern ... benefits may fade by…
Recently, we have reported an active nanostructured collagen implant reinforced with human stem cells for bone regeneration. In our group, we have reported a "Smart Hybrid Materials Equipped with Nanoreservoirs…
rapid progression of the disease may lead to orbital and brain involvement.1-4 In the past, the mortality rate of the rhino-cerebral type was 88%, but recently the survival rate
with the increase in obesity has been the aging of the population. There are progressively fewer younger and older persons, and by the year 2100, the numbers of persons ... that intensive glycemic control is not of…
siRNA complexes with -CDEs via a formation of ternary complexes. I will introduce the recent progress of -CDEs and GUG-- CDEs as cell-selective nonviral vectors
kidney disease progresses, altered nutrition biomarkers are observed which may be related to poor dietary habits. The typical North American diet is low in fruits, vegetables and whole grains high ... emphasis on…
useful catalytic allylic C-H amination of simple olefins is required. Recently we have made progress in developing copper-catalyzed asymmetric allyl amination of alkenes using aryl hydroxylamine as nitrogen
cultures by cultivating predominantly CHO cells for therapeutic protein production. To ensure a healthy progression of the cell culture, it is important to understand and monitor the stages ... control 4 bioreactors…
efficiency and efficacy of these drugs require better understanding on their mechanism of action. Recent studies show that DNA methylation inhibitors have widespread anti-tumor functions and act by modulating ... genes…
PBRM is steroid derivative recently developed in our research group as anticancer agents. PBRM, or 3-{[(16β,17β)-3- (2-bromoethyl)-17-hydroxyestra-1(10,2,4-trien ... 17β-HSD 1), which is thought to play a pivotal role…
produce a biosensor itself, or to facilitate the biosensor’s operation. As technological progress is made, the volumes of fluid involved have reduced and continue to do so. Reactions which ... volumes of fluids, where…
treatments for MM. The use of novel agents (proteasome inhibitors, immunomodulatory agents, recently approved monoclonal antibodies) has led to more options for patients suffering from such a heterogeneous disease…
treatments for MM. The use of novel agents (proteasome inhibitors, immunomodulatory agents, recently approved monoclonal antibodies) has led to more options for patients suffering from such a heterogeneous disease…
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.